Physician Assistant Program year 2025 Reported 2023–2025 Source: CMS Open Payments, 2026 publication

Stephanie Scott

Physician Assistant Bend, OR Physician Assistant

NPI 1033111521 CMS profile 10912797

2042 Ne Williamson Ct, Bend, OR 97701

Open in the dashboard

General payments

$849

23 records reported · program years 2023–2025

Research payments

$0

Paid to them · None reported · program years 2023–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Stephanie Scott of Bend, OR is reported in the CMS Open Payments database as having received $849 across 23 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 65th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $300 11
2024 General $338 9
2023 General $211 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Stephanie Scott
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Stephanie Scott were reported at $300. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Stephanie Scott Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $0 $132 $37–$438 $132
2022 $0 $155 $48–$522 $149
2023 $211 $167 $52–$557 $160
2024 $338 $178 $55–$600 $164
2025 $300 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2023–2025
  1. Jazz Pharmaceuticals Inc. $555 11 payments
  2. Axsome Therapeutics, Inc. $105 5 payments
  3. Inspire Medical Systems, Inc. $61 2 payments
  4. Respicardia, Inc. $52 1 payment
  5. Harmony Biosciences LLC $47 3 payments
  6. Avadel CNS Pharmaceuticals, LLC $29 1 payment

Every payment, record by record

What the payments were for General payments · program years 2023–2025
  1. Food and Beverage $779 22 payments
  2. Education $70 1 payment
Products named General payments · program years 2023–2025
  1. XYWAV $555 11 payments
  2. Sunosi $105 5 payments
  3. INSPIRE $61 2 payments
  4. remede System $52 1 payment
  5. WAKIX Narcoplepsy $33 2 payments
  6. LUMRYZ $29 1 payment
  7. WAKIX Narcolepsy $14 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

191

Median for Physician Assistant: 241

Drug cost

$5,322

Median for Physician Assistant: $4,110

Branded share of claims

22.5%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eszopiclone Generic 14 $1,776
Modafinil Generic 14 $1,530
Pramipexole Dihydrochloride Pramipexole Di-Hcl Brand 43 $606
Armodafinil Generic 16 $474
Trazodone Hcl Generic 38 $455
Gabapentin Generic 23 $217
Prazosin Hcl Generic 14 $114
Pregabalin Generic 11 $91
Clonazepam Generic 18 $59

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 9 billing codes

Paid by Medicare

$58,693

Medicare's payments for the services billed

Medicare patients

516

Average age 73

Services billed

1,442

252 women, 264 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 73%
Arthritis 53%
Ischemic heart disease 31%
Diabetes 30%
Depression 29%
Atrial fibrillation 22%
Heart failure 17%
Chronic kidney disease 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XYWAV
  • JAZZ PHARMACEUTICALS INC. $283
$283 — —
WAKIX
  • Harmony Biosciences LLC $33
$33 — —
Sunosi
  • Axsome Therapeutics, Inc. $22
$22 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

23 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Oregon

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record